It's September, and the chase for performance is on as investors flock into some of the hottest stocks around. We give you 17 that may have a monster final four months.
Tag: biogen
6 More Monster Predictions for Earnings The Week of July 23
[widget id=”text-22″] [widget id=”text-28″] 6 More Monster Predictions for Earnings The Week of July 23 MICHAEL KRAMER AND THE CLIENTS OF MOTT CAPITAL OWN SHARES OF NXPI [widget id=”text-19″] There are plenty of other companies set to report results the week of July 23, then just the six we highlighted yesterday. So here is a …
The Stock Market Is A Battle of Good and Bad As Uncertainty Runs Wild
[widget id=”text-22″] [widget id=”text-23″] The Stock Market Is A Battle of Good and Bad As Uncertainty Runs Wild [widget id=”text-19″] MICHAEL KRAMER OWNS XLF PUTS Michael Kramer and the clients of Mott Capital own shares of NXPI Stocks continued the see-saw action today we have seen for most of 2018. I think the Fed minutes …
Facebook, Alphabet, Tesla, Intel, Biogen, Gilead, Oil – The Daily Rundown June 18
[widget id=”text-24″] [widget id=”text-22″] Facebook, Alphabet, Tesla, Intel, Biogen, Gilead, Oil – The Daily Rundown June 18 MICHAEL KRAMER AND THE CLIENTS OF MOTT CAPITAL OWN SHARES OF TSLA AND GOOGL [widget id=”text-19″] The stock market had another back and forth session with the S&P 500 trading lower on the day, but it was Technology, Energy, …
10 Indicators To Watch In The Stock Market For The Week of May 28
[widget id=”text-22″] [widget id=”text-28″] 10 Indicators To Watch In The Stock Market For The Week of May 28 MICHAEL KRAMER AND THE CLIENTS OF MOTT CAPITAL OWN SHARES OF NFLX & AAPL [widget id=”text-19″] The coming week will be a big week when it comes to data, with inflation and jobs data starting on Wednesday. …
Biotech Stocks May Have Finally Been Unleashed
Biotech Stocks May Have Finally Been Unleashed Michael Kramer and the Clients of Mott Capital Own CELG [widget id=”text-19″] Stocks continued to move higher, led by the Biotech’s, which were up by about 3 percent. There’s something we haven’t said in a long time. The highly anticipated speech regarding drug prices by the President didn’t …
Twitter and AMD Options Stand Out, Is There A Double Top In Biotech?
[widget id=”text-22″] Twitter and AMD Options Stand Out, Is There A Double Top In Biotech? The stock market overall had another dull day, with the S&P 500 down less than 10 bps, closing at 2,747. Like I had mentioned yesterday, the S&P managed to hang around support at 2,746. Again, there is a chance we …
Roku’s Borrow Rate Rises, plus Biogen, Acadia, Tesla, and Nvidia
[widget id=”text-23″] Roku’s Borrow Rate Rises, plus Biogen, Acadia, Tesla, and Nvidia [widget id=”text-19″] The sell-off continued again with the S&P 500 trading down to roughly 2,646, where a sturdy level of support lies. So for now, it looks like we have held, and my guess is that we could have another few points to …
Micron’s Massive Breakout, Plus Skyworks, Lam, Biogen, Alnylam & More
[widget id=”text-23″] Micron’s Massive Breakout, Plus Skyworks, Lam, Biogen, Alnylam & More The stock market was mixed on Monday, with the S&P 500 finishing the day down slightly. Technology and Biotechnology continue to be the best performing sectors in the market, with the Nasdaq Biotech IBB rising by 40 bps, and the Technology ETF XLK …
Biotech and Tech Stocks Are Approaching Make Or Break Moments
[widget id=”text-23″] Biotech and Tech Stocks Are Approaching Make Or Break Moments The stock market picked right up from where it left off last week, with the S&P 500 continuing to surging to 2,721 up about 1.1 percent today. Based on the charts, it seems like we have a pretty good shot of continuing to …
Acadia, Biogen, Celgene, Regeneron In Focus – A Look At The Week Ahead
[widget id=”text-22″] Acadia, Biogen, Celgene, Regeneron In Focus – A Look At The Week Ahead The stock market will look to build on last weeks gains, and it will be a week filled with economic data and Fed talk. The one segment of the market rally that has been missing has been the biotech sector, and …
Biotech Stocks Continue To Soar, More Gains To Come
[widget id=”wordads_sidebar_widget-41″] Biotech Stocks Continue To Soar, More Gains To Come [widget id=”text-16″] Biotech stocks continue to soar, and Biogen and Gilead had big days on Friday. Biogen jumped by nearly 4 percent, taking shares up $368, after reporting robust result on Thursday. Gilead shares jumped by over 5 percent, to over $85, after getting an …
Why Biotech Stocks Will Continue To Reach Record Heights
[widget id=”wordads_sidebar_widget-41″] Why Biotech Stocks Will Continue To Reach Record Heights [widget id=”text-16″] Biotech stocks continue to rip higher, with the S&P Biotech ETF ($XBI) reaching a new record high, and the Nasdaq Biotech ETF ($IBB) quickly running to $122. The XBI is now up by over 12 percent on the year, while the IBB …
What The Market Thinks About Biogen’s Upcoming Results – Premium Content
What The Market Thinks About Biogen’s Upcoming Results In this premium video, we take a look at what the market may be expecting when Biogen reports results on January 25. Why Biotech Stocks Have More Room To Rise – Premium Content A Preview Of Earnings Season [widget id=”wordads_sidebar_widget-41″] [widget id=”text-16″] Photo Credit Via Flickr …
Under Armour, Bitcoin, AMD, Biogen, Gilead, Pfizer – Monster Commentary
[widget id=”wordads_sidebar_widget-41″] Under Armour, Bitcoin, AMD, Biogen, Gilead, Pfizer – Monster Commentary [widget id=”text-16″] S&P 500 The S&P 500 had a relatively uneventful day, with the index finishing the day down less than 20 bps. But the thing to take note of is how the index has now failed right at 2,805 three times. Big …
Stock Market Sells Off As Biotech Gets Rocked, Again!
[widget id=”text-15″] [widget id=”wordads_sidebar_widget-41″] Stock Market Sells Off As Biotech Gets Rocked, Again! Just more of the same isn’t? Gap up at the open, then a slow drag lower the rest of the day. I hate days were the market just gaps up, what is the point? It always just fills the gap. You must …
Bitcoin, AMD, Nvidia, Biotech, Could Apple iPhone Worries Be Overblown
[widget id=”wordads_sidebar_widget-18″] Bitcoin, AMD, Nvidia, Biotech, Could Apple iPhone Worries Be Overblown It is a new year, and with that everything gets reset back to zero, but other than not much else should change when trading opens again on January 2. Bitcoin It seems likely Bitcoin will continue its decline as well. In an Investopedia …
Tesla and Biotech’s Have Soared, While Chips and Tech Still Struggle
Tesla and Biotech’s Have Soared, While Chips and Tech Still Struggle The past couple of trading sessions have seen shares of Tesla rise from roughly $310 to $340, while biotechs have jumped from $102 to $107 on the IBB ETF. Meanwhile, tech and chips have stabilized but are not out of the woods just yet. …
The Week Ahead: Watching – The VIX, Nvidia, Micron, Tesla & Biotech
The Monster Week Ahead: Watching – The VIX, Nvidia, Micron, Tesla & Biotech We could see a much more relaxed market than the one we saw last week. With Tax Reform now through the Senate, the odds seem fairly good that reconciliation can produce a tax bill to be signed by the President by year-end. That …